Related Experiment Video
Updated: Aug 17, 2025

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
Published on: March 15, 2024
The 10-year priapism experience: identifying clearer targets for intervention
Rebecca J Howland1, Stephanie Daignault-Newton1, Yooni A Blair1
1Department of Urology, Michigan Medicine, Ann Arbor, MI, USA.
Emergency medicine (EM) physicians and urologists manage similar priapism cases, with EM patients presenting sooner. Recurrent priapism necessitates targeted outpatient prevention strategies.
Area of Science:
- Urology
- Emergency Medicine
- Clinical Practice
Background:
- Limited data exists on clinical priapism experience.
- Differences in practice patterns between urologists and emergency medicine (EM) physicians are underexplored.
- Understanding priapism patient populations can guide clinical efforts.
Purpose of the Study:
- To analyze the priapism patient population.
- To identify targets for clinical translational efforts in priapism management.
- To compare practice patterns of urologists and EM physicians.
Main Methods:
- Retrospective chart review of two priapism datasets (urology and EM) from June 2008 to July 2018.
- Analysis of patient encounters, duration of priapism, and acute interventions.
- Documentation of time to presentation, prior interventions, and evaluation.
Main Results:
- 396 priapism encounters in 95 unique patients over 10 years.
- Urology managed 199 encounters (83 patients); EM managed 197 encounters (15 patients).
- Median priapism duration was 6 hours for urology and 4 hours for EM; 72% and 89% required intervention, respectively.
- Nine patients accounted for 294 encounters due to recurrent priapism.
Conclusions:
- EM physicians and urologists manage similar numbers of priapism encounters, but EM patients present with shorter duration.
- Tailoring joint curriculum for initial priapism management and focusing complex cases for urology trainees is recommended.
- Recurrent ischemic priapism in a small patient subset highlights the need for outpatient prevention strategies.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Peripheral Artery Disease III: Interprofessional Care
Angina V: Nursing Management
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....

